Suchergebnisse - "Imai, Kanae"

PubPharm (8)

1

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

enthalten in: Molecular cancer therapeutics | 2024

von Imai, K. | Takeuchi, Y. | Terakura, S. | +8

2

Surface force analysis of glycine adsorption on different crystal surfaces of titanium dioxide ($ TiO_{2} $)

enthalten in: Nano Convergence | 2017

von Ganbaatar, N. | Imai, K. | Yano, T. | +1

3

Surface force analysis of glycine adsorption on different crystal surfaces of titanium dioxide (TiO2)

enthalten in: Nano convergence | 2017

von Ganbaatar, N. | Imai, K. | Yano, T. | +1

4

The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation

enthalten in: Internal medicine (Tokyo, Japan) | 2016

von Morishita, T. | Tsushita, N. | Imai, K. | +7

5

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

enthalten in: International journal of hematology | 2014

von Miyao, K. | Sakemura, R. | Imai, K. | +6

6

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

enthalten in: International journal of hematology | 2014

von Miyao, K. | Sakemura, R. | Imai, K. | +6

7

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

enthalten in: International journal of hematology | 2014

von Miyao, K. | Sakemura, R. | Imai, K. | +6

8

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

enthalten in: International journal of hematology | 2014

von Miyao, K. | Sakemura, R. | Imai, K. | +6

1
[1]